The Patent Finder
SM

Swat Medical AB

First filing 2011
OverviewNotableFeesChangesFamiliesPatent listSources & methods

4 patents currently held

11 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Nov 2033. from the record

Of the 11 now held by other companies, 11 name Emboline Inc. as their current owner. Each row says so.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Nov 2033
Next term end
3
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 2 of the currently held patents qualify as notable.

Formerly held, still cited

Notable
The most cited patent in this portfolio, cited by 95 later US patents, top 5% of utility patents granted in 2015 in our data. Protection runs to 2032.
now held by Emboline, Inc.
Ends May 2032 · High confidence
Also notable
Cited by 59 later US patents, top 5% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2035.
now held by Emboline, Inc.
Ends May 2035 · High confidence
Also notable
Cited by 27 later US patents, top 10% of utility patents granted in 2020 in our data. Protection runs to 2029.
now held by Emboline, Inc.
Ends Sep 2029 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Oct 16, 2027
    The maintenance fee for Embolic Protection Device And Method (US 11,957,561) comes due Oct 16, 2027. Unpaid by Apr 17, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 23, 2026

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 4 of 4

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 11,446,132Embolic Protection Device And Method
In force
 · Medium confidence
In forceMedium confidence
US 11,992,398Device And Method For Delivery Of Medical Devices To A Cardiac Valve
In force
 · High confidence
In forceHigh confidence
US 11,957,561Embolic Protection Device And Method
In force
 · Medium confidence
In forceMedium confidence
US 12,472,051Embolic Protection Device and Method
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 4: 11 patents in force now held by others · 1 application abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
2 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited